CRB-601 monoclonal antibody Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Birmingham, Alabama1 trial

First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

University of Alabama at Birmingham

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.